
Dycnos-AQ Injection
Marketer
Ridgecure Pharma
Salt Composition
Diclofenac (75mg)
Overview Dycnos-AQ Injection
Aquodyne injection provides pain relief and manages inflammation, stiffness, and joint pain associated with conditions such as rheumatoid arthritis, osteoarthritis, and acute musculoskeletal trauma. Parenteral administration is indicated when oral medication is infeasible. This injectable medication must be administered by a qualified healthcare provider; self-injection is strictly prohibited. Patients with a history of cardiovascular events (heart disease or stroke) should inform their physician. Report any injection site reactions (pain, swelling, redness) to your doctor immediately. Common adverse effects include nausea, vomiting, headache, and local injection site reactions. For prolonged therapy, regular monitoring of renal and hepatic function, along with blood counts, is recommended. Extended use may increase the risk of serious complications, including gastrointestinal bleeding and renal impairment.
Primary Ingredients of Dycnos-AQ Injection
No text provided to rephrase.
Uses of Dycnos-AQ Injection
Analgesia
Major Benefits of Dycnos-AQ Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Dycnos-AQ Injection:
- Injection site reactions (pain, swelling, redness)
- Vomiting
- Flatulence
- Edema (swelling)
- Nausea
- Headache
- Dizziness
How to use Dycnos-AQ Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Dycnos-AQ Injection works:
Dycnos-AQ Injection is a non-steroidal anti-inflammatory drug (NSAID) that inhibits the production of specific inflammatory mediators responsible for pain and the associated symptoms of redness and swelling.
SAFETY ADVICE
AlcoholCAUTION
Use caution when drinking alcohol while receiving Dycnos-AQ Injection. Physician consultation is recommended.
PregnancyCONSULT YOUR DOCTOR
Administering Dycnos-AQ Injection during pregnancy poses a confirmed risk to the fetus and is therefore contraindicated. In exceptional circumstances involving a life-threatening condition, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is essential.
Breast feedingCONSULT YOUR DOCTOR
Administration of Dycnos-AQ Injection while breastfeeding is likely inadvisable. Preliminary human studies indicate potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Administration of Dycnos-AQ Injection may impair driving ability due to potential adverse reactions.
KidneyCAUTION
Administering Dycnos-AQ Injection to individuals with impaired renal function requires careful monitoring. Dosage modification of Dycnos-AQ Injection might be necessary. Physician consultation is advised.
LiverCAUTION
Exercise caution when administering Dycnos-AQ Injection to individuals with hepatic impairment; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Dycnos-AQ Injection :
Omit a Dycnos-AQ Injection dose? Seek medical advice immediately.
Facts to Know About Dycnos-AQ Injection
| Label | Value |
|---|---|
| Chemical Category | Phenylacetic Acid Analog |
| Developing Good Habits | No. |
| Treatment Category | Pain Relievers |
